OTCPK:SDZXF (Switzerland)
Â
Registered Shares
$
51.98
(0%)
10:08 PM EST
Sandoz Group AG (OTCPK:SDZXF) Stock News, Headlines & Updates
Sandoz Group AG Stock News from GuruFocus
- 1
Jul 01, 2025
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach | SDZNY Stock News
GuruFocus News • 8:15am
Jun 25, 2025
Berenberg Adjusts Price Target for Sandoz (SDZNY) | SDZNY Stock News
GuruFocus News • 12:15pm
Jun 02, 2025
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] | SDZNY Stock News
GuruFocus News • 12:15am
May 21, 2025
Sandoz (SDZNY) Launches Pyzchiva Autoinjector in Europe | SDZNY Stock News
GuruFocus News • 10:46am
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars | SDZNY Stock News
GuruFocus News • 10:45am
May 02, 2025
Sandoz (SDZNY) Upgraded to Outperform by RBC Capital | SDZNY Stock News
GuruFocus News • 3:45am
Apr 30, 2025
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed | SDZNY Stock News
GuruFocus News • 12:15am
Apr 29, 2025
Sandoz (SDZNY) Secures Rights for Yervoy Biosimilar with $332M Deal
GuruFocus News • 10:57am
Sandoz (SDZNY) Partners with Shanghai Henlius for Biosimilar Drug Initiative | SDZNY Stock News
GuruFocus News • 10:30am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news